MORRIS PLAINS, N.J., June 9, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that five presentations will be given at the 55th Annual Meeting of the Society of Nuclear Medicine (SNM), scheduled for June 14 - 18, 2008, in New Orleans, LA. The schedule and meeting places for the scientific paper and scientific poster sessions, together with the publication numbers are listed below:
